AGILENT TECHNOLOGIES INC (A) Fundamental Analysis & Valuation
NYSE:A • US00846U1016
Current stock price
110.24 USD
-3.24 (-2.86%)
At close:
110.24 USD
0 (0%)
After Hours:
This A fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. A Profitability Analysis
1.1 Basic Checks
- In the past year A was profitable.
- In the past year A had a positive cash flow from operations.
- Each year in the past 5 years A has been profitable.
- Each year in the past 5 years A had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 10.07%, A belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.
- The Return On Equity of A (18.67%) is better than 91.07% of its industry peers.
- With an excellent Return On Invested Capital value of 12.56%, A belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for A is in line with the industry average of 12.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.07% | ||
| ROE | 18.67% | ||
| ROIC | 12.56% |
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
1.3 Margins
- Looking at the Profit Margin, with a value of 18.26%, A belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
- A's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 22.04%, A belongs to the best of the industry, outperforming 91.07% of the companies in the same industry.
- A's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 52.60%, A is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
- In the last couple of years the Gross Margin of A has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.04% | ||
| PM (TTM) | 18.26% | ||
| GM | 52.6% |
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
2. A Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), A is creating some value.
- The number of shares outstanding for A has been reduced compared to 1 year ago.
- A has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, A has an improved debt to assets ratio.
2.2 Solvency
- A has an Altman-Z score of 4.60. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.60, A belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
- The Debt to FCF ratio of A is 3.38, which is a good value as it means it would take A, 3.38 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of A (3.38) is better than 82.14% of its industry peers.
- A Debt/Equity ratio of 0.49 indicates that A is not too dependend on debt financing.
- The Debt to Equity ratio of A (0.49) is worse than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 3.38 | ||
| Altman-Z | 4.6 |
ROIC/WACC1.17
WACC10.74%
2.3 Liquidity
- A has a Current Ratio of 2.07. This indicates that A is financially healthy and has no problem in meeting its short term obligations.
- A has a worse Current ratio (2.07) than 62.50% of its industry peers.
- A Quick Ratio of 1.59 indicates that A should not have too much problems paying its short term obligations.
- A has a worse Quick ratio (1.59) than 62.50% of its industry peers.
- A does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.59 |
3. A Growth Analysis
3.1 Past
- A shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.03%.
- Measured over the past years, A shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.21% on average per year.
- A shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.14%.
- Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 5.41% on average per year.
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%
3.2 Future
- The Earnings Per Share is expected to grow by 9.72% on average over the next years. This is quite good.
- A is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.00% yearly.
EPS Next Y8.97%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
EPS Next 5Y9.72%
Revenue Next Year6.82%
Revenue Next 2Y6.46%
Revenue Next 3Y6.47%
Revenue Next 5Y6%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. A Valuation Analysis
4.1 Price/Earnings Ratio
- A is valuated rather expensively with a Price/Earnings ratio of 19.58.
- Based on the Price/Earnings ratio, A is valued cheaper than 83.93% of the companies in the same industry.
- A's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.88.
- Based on the Price/Forward Earnings ratio of 16.48, the valuation of A can be described as correct.
- 82.14% of the companies in the same industry are more expensive than A, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, A is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.58 | ||
| Fwd PE | 16.48 |
4.2 Price Multiples
- 76.79% of the companies in the same industry are more expensive than A, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, A is valued a bit cheaper than 67.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.37 | ||
| EV/EBITDA | 18.13 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)2.18
PEG (5Y)1.75
EPS Next 2Y9.5%
EPS Next 3Y10.1%
5. A Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.90%, A is not a good candidate for dividend investing.
- In the last 3 months the price of A has falen by -20.34%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- A's Dividend Yield is rather good when compared to the industry average which is at 0.11. A pays more dividend than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, A's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
- On average, the dividend of A grows each year by 6.57%, which is quite nice.
- A has been paying a dividend for at least 10 years, so it has a reliable track record.
- A has decreased its dividend recently.
Dividend Growth(5Y)6.57%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- 21.94% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
- A's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.94%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
A Fundamentals: All Metrics, Ratios and Statistics
110.24
-3.24 (-2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)05-26 2026-05-26/amc
Inst Owners92.52%
Inst Owner Change-0.33%
Ins Owners0.13%
Ins Owner Change3.18%
Market Cap31.15B
Revenue(TTM)7.07B
Net Income(TTM)1.29B
Analysts78.62
Price Target166.11 (50.68%)
Short Float %1.62%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.94%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31 2026-03-31 (0.255)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.09%
Min EPS beat(2)-2.58%
Max EPS beat(2)-1.6%
EPS beat(4)1
Avg EPS beat(4)-1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.21%
EPS beat(12)8
Avg EPS beat(12)0.61%
EPS beat(16)11
Avg EPS beat(16)1.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)-0.43%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)2.3%
Revenue beat(8)2
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)0.07%
PT rev (1m)0%
PT rev (3m)0.57%
EPS NQ rev (1m)0.92%
EPS NQ rev (3m)0.88%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)1.89%
Revenue NQ rev (3m)1.89%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.58 | ||
| Fwd PE | 16.48 | ||
| P/S | 4.41 | ||
| P/FCF | 31.37 | ||
| P/OCF | 22.32 | ||
| P/B | 4.51 | ||
| P/tB | 15.59 | ||
| EV/EBITDA | 18.13 |
EPS(TTM)5.63
EY5.11%
EPS(NY)6.69
Fwd EY6.07%
FCF(TTM)3.51
FCFY3.19%
OCF(TTM)4.94
OCFY4.48%
SpS25
BVpS24.44
TBVpS7.07
PEG (NY)2.18
PEG (5Y)1.75
Graham Number55.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.07% | ||
| ROE | 18.67% | ||
| ROCE | 14.72% | ||
| ROIC | 12.56% | ||
| ROICexc | 14.98% | ||
| ROICexgc | 32.42% | ||
| OM | 22.04% | ||
| PM (TTM) | 18.26% | ||
| GM | 52.6% | ||
| FCFM | 14.06% |
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score6
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 3.38 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 142.4% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | 15.73 | ||
| Cash Conversion | 75.87% | ||
| Profit Quality | 76.98% | ||
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 4.6 |
F-Score6
WACC10.74%
ROIC/WACC1.17
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
EPS Next Y8.97%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
EPS Next 5Y9.72%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%
Revenue Next Year6.82%
Revenue Next 2Y6.46%
Revenue Next 3Y6.47%
Revenue Next 5Y6%
EBIT growth 1Y0.19%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year27.75%
EBIT Next 3Y14.3%
EBIT Next 5Y11.62%
FCF growth 1Y-39.78%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-28.81%
OCF growth 3Y5.92%
OCF growth 5Y11.1%
AGILENT TECHNOLOGIES INC / A Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?
ChartMill assigns a fundamental rating of 7 / 10 to A.
Can you provide the valuation status for AGILENT TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 5 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.
Can you provide the profitability details for AGILENT TECHNOLOGIES INC?
AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.
What is the valuation of AGILENT TECHNOLOGIES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 19.58 and the Price/Book (PB) ratio is 4.51.
Can you provide the dividend sustainability for A stock?
The dividend rating of AGILENT TECHNOLOGIES INC (A) is 5 / 10 and the dividend payout ratio is 21.94%.